Microbial fermentation is the basis for the production of a wide range of high value biopharmaceutical products, including antibiotics, vaccines, and therapeutic proteins. NHB intends to deliver production and operational cost savings and efficiencies with its new SUHF™ system that will fundamentally improve the global competitive edge of its users.